These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 1446315

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An adenosine A1 receptor agonist, R(-)-N-(2-phenylisopropyl)-adenosine (PIA), but not adenosine itself, acts as a therapeutic preconditioning-mimetic agent in rabbits.
    Hale SL, Bellows SD, Hammerman H, Kloner RA.
    Cardiovasc Res; 1993 Dec; 27(12):2140-5. PubMed ID: 8313421
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Limitation of myocardial infarct size by adenosine A1 receptor activation is abolished by protein kinase C inhibitors in the rabbit.
    Sakamoto J, Miura T, Goto M, Iimura O.
    Cardiovasc Res; 1995 May; 29(5):682-8. PubMed ID: 7606758
    [Abstract] [Full Text] [Related]

  • 5. The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart.
    Tsuchida A, Thompson R, Olsson RA, Downey JM.
    J Mol Cell Cardiol; 1994 Mar; 26(3):303-11. PubMed ID: 8028014
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of R-PIA, a selective A1 adenosine agonist, on haemodynamics and ischaemic arrhythmias in pigs.
    Wainwright CL, Parratt JR.
    Cardiovasc Res; 1993 Jan; 27(1):84-9. PubMed ID: 8458036
    [Abstract] [Full Text] [Related]

  • 8. Loss of myocardial protection from ischemic preconditioning following chronic exposure to R(-)-N6-(2-phenylisopropyl)adenosine is related to defect at the adenosine A1 receptor.
    Hashimi MW, Thornton JD, Downey JM, Cohen MV.
    Mol Cell Biochem; 1998 Sep; 186(1-2):19-25. PubMed ID: 9774181
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Attenuation of postischaemic dysfunction by ischaemic preconditioning is not mediated by adenosine in the isolated rat heart.
    Asimakis GK, Inners-McBride K, Conti VR.
    Cardiovasc Res; 1993 Aug; 27(8):1522-30. PubMed ID: 8221807
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pretreatment with the adenosine A1 selective agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbits.
    Tsuchida A, Liu GS, Wilborn WH, Downey JM.
    Cardiovasc Res; 1993 Apr; 27(4):652-6. PubMed ID: 8324800
    [Abstract] [Full Text] [Related]

  • 17. Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation.
    Miura T, Liu Y, Kita H, Ogawa T, Shimamoto K.
    J Am Coll Cardiol; 2000 Jan; 35(1):238-45. PubMed ID: 10636286
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation.
    Miki T, Miura T, Ura N, Ogawa T, Suzuki K, Shimamoto K, Iimura O.
    J Am Coll Cardiol; 1996 Nov 15; 28(6):1616-22. PubMed ID: 8917279
    [Abstract] [Full Text] [Related]

  • 20. Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts.
    Hoshida S, Kuzuya T, Nishida M, Yamashita N, Oe H, Hori M, Kamada T, Tada M.
    Cardiovasc Res; 1994 Jul 15; 28(7):1083-8. PubMed ID: 7954595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.